Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Creates Life-Science Advisory Board

NEW YORK, Feb. 6 - Agilent Technologies has formed a life-sciences advisory board "to identify and evaluate technologies and applications" in the biotech sector, the company said Feb. 4.

 

"This is one more step toward accelerating our growth as a leading supplier of gene expression, proteomics and pharmaceutical analysis solutions," Chris Van Ingen, general manager of Agilent's life sciences and chemical analysis division, said in a statement.

 

Members of the board, which is expected to meet two or three times each year, include Paul Herring, director of corporate research at Novartis International; Anthony Martin, president and CEO of Molecular Probes.; Mark Skolnick, founder of Myriad Genetics; and, Wendell Wierenga, CEO of Syrrx.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.